Ritchie Edward Brown, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parvalbumins | 10 | 2022 | 246 | 1.410 |
Why?
|
| Wakefulness | 12 | 2021 | 1243 | 1.380 |
Why?
|
| Neurons | 22 | 2022 | 9325 | 1.140 |
Why?
|
| Arousal | 5 | 2022 | 1165 | 1.080 |
Why?
|
| Histamine | 12 | 2003 | 507 | 1.050 |
Why?
|
| Sleep | 13 | 2022 | 4604 | 0.940 |
Why?
|
| Prosencephalon | 3 | 2016 | 303 | 0.910 |
Why?
|
| Neuropeptides | 10 | 2010 | 942 | 0.880 |
Why?
|
| gamma-Aminobutyric Acid | 11 | 2022 | 1123 | 0.880 |
Why?
|
| Sleep, REM | 7 | 2020 | 594 | 0.880 |
Why?
|
| Glutamate Decarboxylase | 4 | 2014 | 246 | 0.840 |
Why?
|
| Synaptic Transmission | 10 | 2013 | 1179 | 0.800 |
Why?
|
| Cholinergic Agents | 2 | 2021 | 93 | 0.770 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 10 | 2010 | 2906 | 0.720 |
Why?
|
| Patch-Clamp Techniques | 11 | 2018 | 963 | 0.700 |
Why?
|
| Dentate Gyrus | 5 | 1999 | 160 | 0.680 |
Why?
|
| Action Potentials | 8 | 2017 | 1814 | 0.670 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2018 | 152 | 0.590 |
Why?
|
| Schizophrenia | 6 | 2020 | 6874 | 0.550 |
Why?
|
| Carbachol | 3 | 2017 | 226 | 0.540 |
Why?
|
| Glutamates | 1 | 2017 | 398 | 0.530 |
Why?
|
| Excitatory Amino Acid Antagonists | 3 | 2018 | 449 | 0.500 |
Why?
|
| Neurotransmitter Agents | 5 | 2009 | 647 | 0.490 |
Why?
|
| Ventral Tegmental Area | 4 | 2004 | 142 | 0.460 |
Why?
|
| Parasympathetic Nervous System | 1 | 2014 | 141 | 0.450 |
Why?
|
| Rats, Wistar | 17 | 2003 | 1902 | 0.450 |
Why?
|
| Long-Term Potentiation | 8 | 2006 | 293 | 0.440 |
Why?
|
| Receptors, Histamine H3 | 5 | 2001 | 9 | 0.440 |
Why?
|
| Electroencephalography | 13 | 2022 | 6142 | 0.430 |
Why?
|
| Raphe Nuclei | 3 | 2003 | 104 | 0.420 |
Why?
|
| Substantia Nigra | 3 | 2004 | 353 | 0.420 |
Why?
|
| Green Fluorescent Proteins | 4 | 2014 | 2088 | 0.420 |
Why?
|
| Carrier Proteins | 7 | 2004 | 5019 | 0.390 |
Why?
|
| Adenosine | 3 | 2018 | 823 | 0.390 |
Why?
|
| Receptors, Neuropeptide | 7 | 2013 | 111 | 0.370 |
Why?
|
| Glutamic Acid | 4 | 2021 | 1167 | 0.360 |
Why?
|
| Cerebral Cortex | 3 | 2014 | 5705 | 0.350 |
Why?
|
| Vesicular Glutamate Transport Protein 2 | 2 | 2021 | 54 | 0.350 |
Why?
|
| Receptors, Metabotropic Glutamate | 3 | 1995 | 212 | 0.340 |
Why?
|
| Ketamine | 2 | 2013 | 499 | 0.340 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2009 | 112 | 0.340 |
Why?
|
| Serotonin | 3 | 2003 | 1024 | 0.340 |
Why?
|
| Animals | 54 | 2022 | 168561 | 0.330 |
Why?
|
| Veterans | 1 | 2022 | 2513 | 0.320 |
Why?
|
| Reticular Formation | 1 | 2008 | 61 | 0.310 |
Why?
|
| Membrane Potentials | 7 | 2014 | 1135 | 0.310 |
Why?
|
| Brain Waves | 3 | 2019 | 400 | 0.310 |
Why?
|
| Sleep Deprivation | 3 | 2009 | 830 | 0.300 |
Why?
|
| Hypothalamic Area, Lateral | 4 | 2003 | 104 | 0.300 |
Why?
|
| Pyramidal Cells | 1 | 2009 | 363 | 0.290 |
Why?
|
| Hippocampus | 8 | 2022 | 3661 | 0.290 |
Why?
|
| Cholinergic Agonists | 1 | 2006 | 74 | 0.280 |
Why?
|
| Mice | 24 | 2022 | 81045 | 0.280 |
Why?
|
| Gene Knock-In Techniques | 3 | 2013 | 418 | 0.270 |
Why?
|
| Rats | 24 | 2013 | 24265 | 0.270 |
Why?
|
| Dopamine | 5 | 2004 | 1589 | 0.260 |
Why?
|
| Pons | 1 | 2006 | 245 | 0.260 |
Why?
|
| Tetrodotoxin | 4 | 2017 | 258 | 0.260 |
Why?
|
| Receptors, G-Protein-Coupled | 7 | 2013 | 1221 | 0.230 |
Why?
|
| Cell Membrane | 1 | 2013 | 3744 | 0.220 |
Why?
|
| Neural Inhibition | 2 | 2006 | 598 | 0.210 |
Why?
|
| Receptors, Glutamate | 2 | 2018 | 232 | 0.200 |
Why?
|
| Alzheimer Disease | 1 | 2022 | 7988 | 0.200 |
Why?
|
| Prefrontal Cortex | 1 | 2011 | 2146 | 0.190 |
Why?
|
| Homeostasis | 2 | 2010 | 3335 | 0.190 |
Why?
|
| Animals, Genetically Modified | 2 | 2017 | 1546 | 0.190 |
Why?
|
| Carbazoles | 1 | 2002 | 226 | 0.180 |
Why?
|
| Calcium Channels, T-Type | 1 | 2020 | 34 | 0.180 |
Why?
|
| Excitatory Amino Acid Agonists | 3 | 1997 | 147 | 0.180 |
Why?
|
| Avoidance Learning | 1 | 2021 | 233 | 0.180 |
Why?
|
| Mice, Transgenic | 3 | 2019 | 9735 | 0.180 |
Why?
|
| Neostriatum | 1 | 2001 | 250 | 0.170 |
Why?
|
| Thalamus | 2 | 2022 | 1023 | 0.170 |
Why?
|
| Purinergic P2 Receptor Agonists | 1 | 2018 | 14 | 0.170 |
Why?
|
| Electric Stimulation | 4 | 2017 | 1770 | 0.170 |
Why?
|
| Histamine Antagonists | 4 | 2002 | 93 | 0.170 |
Why?
|
| Acoustic Stimulation | 2 | 2020 | 1216 | 0.170 |
Why?
|
| Thalamic Nuclei | 1 | 2019 | 114 | 0.160 |
Why?
|
| Evoked Potentials, Auditory | 2 | 2019 | 525 | 0.160 |
Why?
|
| Purinergic P2 Receptor Antagonists | 1 | 2018 | 71 | 0.160 |
Why?
|
| Calcium Channel Blockers | 3 | 2017 | 689 | 0.160 |
Why?
|
| Narcolepsy | 3 | 2009 | 195 | 0.160 |
Why?
|
| Theta Rhythm | 2 | 2004 | 207 | 0.160 |
Why?
|
| Carbohydrates | 1 | 2020 | 391 | 0.160 |
Why?
|
| Electrodes, Implanted | 2 | 2018 | 824 | 0.150 |
Why?
|
| Neuronal Plasticity | 4 | 2015 | 1418 | 0.150 |
Why?
|
| Histamine Agonists | 1 | 1996 | 11 | 0.150 |
Why?
|
| Animals, Newborn | 2 | 2017 | 2723 | 0.150 |
Why?
|
| Neural Pathways | 3 | 2012 | 2971 | 0.150 |
Why?
|
| Luminescent Proteins | 2 | 2017 | 853 | 0.140 |
Why?
|
| Excitatory Postsynaptic Potentials | 5 | 2002 | 377 | 0.140 |
Why?
|
| Azetidinecarboxylic Acid | 1 | 1995 | 4 | 0.140 |
Why?
|
| Sodium Channel Blockers | 1 | 2017 | 176 | 0.140 |
Why?
|
| Cycloleucine | 1 | 1995 | 9 | 0.140 |
Why?
|
| Electrophysiology | 5 | 2002 | 1309 | 0.140 |
Why?
|
| Ion Channels | 3 | 2014 | 1056 | 0.130 |
Why?
|
| Neurotoxins | 1 | 1995 | 237 | 0.120 |
Why?
|
| Auditory Perception | 1 | 2019 | 568 | 0.120 |
Why?
|
| Glycine | 2 | 1995 | 671 | 0.120 |
Why?
|
| Muscarinic Agonists | 1 | 2014 | 87 | 0.120 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2014 | 150 | 0.120 |
Why?
|
| Rats, Sprague-Dawley | 7 | 2013 | 8300 | 0.120 |
Why?
|
| Immunohistochemistry | 4 | 2014 | 11363 | 0.120 |
Why?
|
| Receptors, Muscarinic | 1 | 2014 | 156 | 0.120 |
Why?
|
| Receptors, GABA-A | 2 | 2022 | 627 | 0.110 |
Why?
|
| Tegmentum Mesencephali | 1 | 2013 | 59 | 0.110 |
Why?
|
| Brain | 4 | 2017 | 26343 | 0.110 |
Why?
|
| Benzoates | 1 | 1994 | 217 | 0.110 |
Why?
|
| Interneurons | 2 | 2011 | 576 | 0.110 |
Why?
|
| Lysine | 1 | 2017 | 1008 | 0.110 |
Why?
|
| Piperidines | 2 | 2017 | 1602 | 0.110 |
Why?
|
| Male | 31 | 2019 | 349538 | 0.110 |
Why?
|
| Receptors, Histamine | 2 | 2002 | 22 | 0.100 |
Why?
|
| Synapses | 2 | 2005 | 1724 | 0.100 |
Why?
|
| Adenosine Triphosphate | 1 | 2018 | 2024 | 0.100 |
Why?
|
| Models, Animal | 1 | 2018 | 2170 | 0.100 |
Why?
|
| Locus Coeruleus | 2 | 2010 | 176 | 0.100 |
Why?
|
| Benzamides | 1 | 2017 | 1378 | 0.100 |
Why?
|
| Evoked Potentials | 2 | 2013 | 1057 | 0.100 |
Why?
|
| Darkness | 1 | 2010 | 167 | 0.090 |
Why?
|
| Pyrimidines | 2 | 2017 | 2933 | 0.090 |
Why?
|
| Receptor, Adenosine A1 | 1 | 2009 | 44 | 0.090 |
Why?
|
| Synaptic Membranes | 1 | 2009 | 87 | 0.090 |
Why?
|
| Organ Culture Techniques | 1 | 2011 | 808 | 0.080 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2017 | 1538 | 0.080 |
Why?
|
| Nitric Oxide Synthase | 2 | 2001 | 916 | 0.070 |
Why?
|
| alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 2 | 1997 | 70 | 0.070 |
Why?
|
| Cognition | 2 | 2015 | 6722 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2012 | 4465 | 0.070 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 895 | 0.070 |
Why?
|
| Spatial Behavior | 1 | 2006 | 90 | 0.070 |
Why?
|
| Basal Nucleus of Meynert | 1 | 2005 | 26 | 0.070 |
Why?
|
| Analgesics | 1 | 2013 | 1037 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 1655 | 0.070 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2006 | 375 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2006 | 876 | 0.060 |
Why?
|
| Models, Neurological | 1 | 2013 | 1771 | 0.060 |
Why?
|
| Electromyography | 3 | 2017 | 1391 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2008 | 1866 | 0.060 |
Why?
|
| Maze Learning | 1 | 2006 | 478 | 0.060 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 18006 | 0.060 |
Why?
|
| Norepinephrine | 2 | 2004 | 909 | 0.060 |
Why?
|
| Cardiotonic Agents | 1 | 2006 | 535 | 0.060 |
Why?
|
| Adrenergic alpha-1 Receptor Agonists | 1 | 2002 | 19 | 0.060 |
Why?
|
| Up-Regulation | 2 | 2009 | 4211 | 0.050 |
Why?
|
| Receptors, Adrenergic, alpha-1 | 1 | 2002 | 48 | 0.050 |
Why?
|
| Memory | 1 | 2012 | 2163 | 0.050 |
Why?
|
| Sleep Stages | 2 | 2017 | 686 | 0.050 |
Why?
|
| Thapsigargin | 1 | 2002 | 104 | 0.050 |
Why?
|
| Calcium Channels | 2 | 2003 | 621 | 0.050 |
Why?
|
| GABA Antagonists | 1 | 2002 | 128 | 0.050 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2002 | 177 | 0.050 |
Why?
|
| Hypothalamic Hormones | 1 | 2003 | 147 | 0.050 |
Why?
|
| Pituitary Hormones | 1 | 2003 | 183 | 0.050 |
Why?
|
| Mossy Fibers, Hippocampal | 1 | 2001 | 30 | 0.050 |
Why?
|
| Attention | 1 | 2012 | 2396 | 0.050 |
Why?
|
| Humans | 15 | 2022 | 742088 | 0.050 |
Why?
|
| Proteomics | 2 | 2012 | 3618 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2003 | 4751 | 0.050 |
Why?
|
| Melanins | 1 | 2003 | 288 | 0.050 |
Why?
|
| Quality of Life | 1 | 2022 | 12730 | 0.050 |
Why?
|
| Appetite Regulation | 1 | 2001 | 88 | 0.050 |
Why?
|
| Emotions | 1 | 2012 | 2657 | 0.050 |
Why?
|
| Animal Feed | 1 | 2020 | 110 | 0.050 |
Why?
|
| Receptors, GABA | 1 | 2002 | 288 | 0.050 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2001 | 154 | 0.050 |
Why?
|
| Anesthetics, Local | 1 | 2006 | 984 | 0.040 |
Why?
|
| Purinergic P1 Receptor Antagonists | 1 | 1999 | 45 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2012 | 23387 | 0.040 |
Why?
|
| Acetylcholine | 2 | 2016 | 621 | 0.040 |
Why?
|
| 4-Aminopyridine | 1 | 1999 | 81 | 0.040 |
Why?
|
| Potassium Channel Blockers | 1 | 1999 | 171 | 0.040 |
Why?
|
| Injections, Intraventricular | 1 | 1998 | 230 | 0.040 |
Why?
|
| Histamine H1 Antagonists | 1 | 1998 | 100 | 0.040 |
Why?
|
| Cyclic AMP | 2 | 2001 | 1470 | 0.040 |
Why?
|
| Receptors, Presynaptic | 1 | 1996 | 15 | 0.040 |
Why?
|
| Tetanus | 1 | 1997 | 53 | 0.040 |
Why?
|
| Histamine H2 Antagonists | 1 | 1998 | 165 | 0.040 |
Why?
|
| Sodium | 1 | 2002 | 1627 | 0.040 |
Why?
|
| Electrophysiological Phenomena | 1 | 2019 | 316 | 0.040 |
Why?
|
| Genomics | 1 | 2012 | 5692 | 0.030 |
Why?
|
| Picrotoxin | 1 | 1995 | 65 | 0.030 |
Why?
|
| Resorcinols | 1 | 1995 | 38 | 0.030 |
Why?
|
| Microdialysis | 1 | 2016 | 158 | 0.030 |
Why?
|
| Biological Assay | 1 | 2019 | 652 | 0.030 |
Why?
|
| Pyrilamine | 1 | 1995 | 12 | 0.030 |
Why?
|
| Pyrroles | 1 | 2002 | 1143 | 0.030 |
Why?
|
| Cimetidine | 1 | 1995 | 78 | 0.030 |
Why?
|
| Receptors, AMPA | 1 | 1997 | 331 | 0.030 |
Why?
|
| Cholinergic Antagonists | 1 | 2016 | 165 | 0.030 |
Why?
|
| Kinetics | 1 | 2003 | 6474 | 0.030 |
Why?
|
| Phenotype | 1 | 2012 | 16331 | 0.030 |
Why?
|
| N-Methylaspartate | 1 | 1995 | 231 | 0.030 |
Why?
|
| Ion Channel Gating | 1 | 1996 | 437 | 0.030 |
Why?
|
| Indoles | 1 | 2002 | 1834 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 6171 | 0.030 |
Why?
|
| Axons | 1 | 2001 | 1681 | 0.030 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 3504 | 0.030 |
Why?
|
| Photoperiod | 1 | 2013 | 136 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 913 | 0.030 |
Why?
|
| Enzyme Inhibitors | 2 | 2001 | 3800 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2003 | 2623 | 0.020 |
Why?
|
| Hypnotics and Sedatives | 1 | 2019 | 1158 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 17400 | 0.020 |
Why?
|
| Microinjections | 1 | 2010 | 326 | 0.020 |
Why?
|
| Rats, Transgenic | 1 | 2009 | 71 | 0.020 |
Why?
|
| Data Collection | 1 | 2019 | 3339 | 0.020 |
Why?
|
| Photic Stimulation | 1 | 2016 | 2027 | 0.020 |
Why?
|
| Dog Diseases | 1 | 2009 | 136 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2001 | 534 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2001 | 689 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 10943 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2003 | 19223 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 2714 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2013 | 1538 | 0.020 |
Why?
|
| Synaptosomal-Associated Protein 25 | 1 | 2005 | 52 | 0.020 |
Why?
|
| GAP-43 Protein | 1 | 2005 | 152 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2005 | 279 | 0.020 |
Why?
|
| Female | 4 | 2019 | 379592 | 0.020 |
Why?
|
| Corticosterone | 1 | 2006 | 310 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2019 | 21821 | 0.020 |
Why?
|
| Mice, Knockout | 3 | 2009 | 14554 | 0.020 |
Why?
|
| Dogs | 1 | 2009 | 3910 | 0.020 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2004 | 178 | 0.010 |
Why?
|
| RNA, Messenger | 2 | 2013 | 13029 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 1999 | 5522 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 2010 | 1882 | 0.010 |
Why?
|
| Histidine Decarboxylase | 1 | 2001 | 10 | 0.010 |
Why?
|
| Autoreceptors | 1 | 2001 | 3 | 0.010 |
Why?
|
| Tubulin | 1 | 2005 | 695 | 0.010 |
Why?
|
| Nitroarginine | 1 | 2001 | 66 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 2001 | 76 | 0.010 |
Why?
|
| Diet | 1 | 2020 | 7923 | 0.010 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2001 | 91 | 0.010 |
Why?
|
| Presynaptic Terminals | 1 | 2004 | 302 | 0.010 |
Why?
|
| Bacterial Proteins | 1 | 2015 | 3843 | 0.010 |
Why?
|
| Nickel | 1 | 2001 | 130 | 0.010 |
Why?
|
| Protein Subunits | 1 | 2003 | 960 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 7721 | 0.010 |
Why?
|
| Algorithms | 1 | 2019 | 13853 | 0.010 |
Why?
|
| Receptors, Histamine H2 | 1 | 1997 | 18 | 0.010 |
Why?
|
| Receptors, Histamine H1 | 1 | 1997 | 18 | 0.010 |
Why?
|
| Biogenic Amines | 1 | 1997 | 50 | 0.010 |
Why?
|
| Cyclic GMP | 1 | 1999 | 408 | 0.010 |
Why?
|
| Potassium | 1 | 2001 | 1336 | 0.010 |
Why?
|
| Second Messenger Systems | 1 | 1997 | 206 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 19862 | 0.010 |
Why?
|
| Cell Separation | 1 | 2001 | 1749 | 0.010 |
Why?
|
| Extracellular Space | 1 | 1997 | 594 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1997 | 491 | 0.010 |
Why?
|
| Time Factors | 1 | 1995 | 40054 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2004 | 2774 | 0.010 |
Why?
|
| Gene Expression | 1 | 2003 | 7790 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1997 | 14720 | 0.000 |
Why?
|